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483 A NOVEL CELLULAR IMPLANTATION SYSTEM USING AN
INJECTABLE ULTRA-PURIFIED ALGINATE GEL FOR
ARTHROSCOPIC REPAIR OF OSTEOCHONDRAL DEFECTS
T. Igarashi, N. Iwasaki, Y. Kasahara, A. Minami. Department of
Orthopaedic Surgery, Hokkaido University School of Medicine, Sapporo,
JAPAN
Purpose: To determine the superiority of chondrogenic potential from
BMSCs using an ultra-puriﬁed alginate gel over a commercial grade one
and to assess the reparative tissues treated with BMSCs and a puriﬁed
alginate in rabbit cartilage defect model.
Methods: Ultra-puriﬁed alginate (Sea Matrix®, Mochida Pharma., Japan,
endotoxin level of 5.76 EU/g) and commercial grade one (Sodium Alginate
500, Wako, Japan, endotoxin level of 75,950 EU/g) were prepared.
Cytotoxicity of CaCl2 : BMSCs in alginate were exposed to 50, 100, 200,
and 400mM CaCl2. The living cells were counted with Cell Counting
Kit-8 (CCK-8). Proliferation assay : BMSCs encapsulated in puriﬁed and
commercial grade alginate beads were cultured in DMEM with 10%
FBS. At 0, 1, 2, 3, and 7 days, the viable cells were counted with
CCK-8. Alginate beads culture: Alginate beads containing BMSCs were
cultured in chondrogenic medium containing TGF-b3. At 7 and 14 days,
relative gene expressions were analyzed by real-time RT-PCR. At 14 and
21 days, each alginate bead was histologically evaluated. Rabbit model:
The defects (Ø5mm) were created in the patella groove and divided
into ﬁve groups: defect (no treatment); CAlg, commercial grade alginate
alone; CAlgC, commercial grade alginate with BMSCs; PAlg, puriﬁed
alginate alone; PAlgC, puriﬁed alginate with BMSCs. To avoid excessive
exposure to a cytotoxic CaCl2, CaCl2 was injected to the surface of
alginate. It needed no any ﬁxation. In-vivo evaluation: At 4 and 12 weeks,
the macroscopic and histological ﬁndings were scored with a grading
scale, and the mechanical properties were measured by indentation test.
Cadaver model: The stained alginate gel was injected into the defect
with our novel technique. After the operation, manual mobilization was
intermittently performed. Statistical Analysis: Comparison was assessed
by an ANOVA followed by multiple-comparison post hoc tests. P< 0.05
was statistically considered signiﬁcant.
Results: Cytotoxicity of CaCl2 : The cell number in the 200 and 400mM
groups signiﬁcantly decreased, compared to the other groups (p< 0.05).
Proliferation assay : From 1 to 7 days, the number of living cells in the
puriﬁed alginate gel was signiﬁcantly higher (p< 0.05). Alginate beads
culture: The levels of aggrecan and sox 9 genes in the puriﬁed alginate
at 14 days were signiﬁcantly higher (p< 0.05). The proliferated BMSCs
and a newly synthesized matrix were observed within pore spaces in the
both alginate. Rabbit model: The surface of the defect group was rough
and depressed. In the PAlg and PAlgC groups, the defects were substi-
tuted with ﬁrm and white cartilage-like tissue. The macroscopic score at
12 weeks in the PAlgC group was signiﬁcantly superior to the CAlg and
CAlgC groups (p< 0.05). Histological ﬁndings: In the CAlg and CAlgC
groups, residual alginate gels were found, and inﬂammatory reactions
were found in subchondral bone lesion. The PAlgC group exhibited the
normal cartilaginous structures. The histological scores at 12 weeks were
signiﬁcantly higher in the PAlg and PAlgC groups than in the defect and
CAlg groups (p< 0.05). Mechanical properties: From 4 to 12 weeks, the
modulus of the CAlgC and PAlgC groups signiﬁcantly improved (p< 0.05)
and approximately reached to 80% of normal. Cadaver model: After
mobilization, the alginate gel was not detached and maintained the initial
shape and hardness.
Conclusions: We conﬁrm that the puriﬁed alginate gel has a great
promise as a cell-carrier material for a clinical immnoisolated implantation
of cells into cartilage defects. This study showed a clinical possibility
of arthroscopic implantation using the current injectable system to the
articular cartilaginous lesions.
484 CATABOLIC FACTORS AND OSTEOARTHRITIS-
CONDITIONED MEDIUM INHIBIT CHONDROGENESIS OF
HUMAN MESENCHYMAL STEM CELLS
G. Heldens1, E. Vitters1, W. Schreurs1, E. Piek2, W. van den Berg1,
P. van der Kraan1. 1UMC St Radboud, Nijmegen, NETHERLANDS,
2Radboud University Nijmegen, Nijmegen, NETHERLANDS
Purpose: Articular cartilage shows poor intrinsic repair, leading to
progressive joint damage. Therapies like marrow stimulation or tissue
engineering of cartilage depend on the chondrogenic differentiation of
progenitor cells. However, this chondrogenic differentiation needs to take
place in a diseased joint with an altered environment. We postulate
that catabolic factors in this environment will inhibit chondrogenesis of
progenitor cells.
Methods: We examined the effect of interleukin-1 (Il-1) and tumour
necrosis factor alpha (TNFalpha) on human mesenchymal stem cells
undergoing chondrogenic differentiation. In addition, osteoarthritis syn-
ovium derived conditioned medium was added to human mesenchymal
stem cells undergoing chondrogenic differentiation. Chondrogenesis was
examined by determining the mRNA levels of the chondrogenic markers
collagen type II and aggrecan. Additionally, the hypertrophy marker col-
lagen type X was examined. Proteoglycan deposition was analyzed by
safranin O staining of histological sections.
Results: Chondrogenesis of human mesenchymal stem cells, as deter-
mined by safranin O proteoglycan staining, was completely abolished
at day 14 by adding Il-1 (10 ng/mL) from day 0, 3, 7 and 10 onwards.
Under these conditions the expression of type II collagen and aggrecan
mRNA as well as the hypertrophy marker collagen type X were also
blocked completely, except by late addition of Il-1 (day 10), resulting in
only a partial inhibition of these mRNA markers. Il-1 appears to be a very
potent inhibitor of chondrogenesis, not only at the onset, but throughout
the process of chondrogenesis
Il-1 as well as TNF-alpha inhibited chondrogenesis in a dose-dependent
manner. Even at the lowest dose tested (0.1 ng/mL) Il-1 and TNFalpha
downregulated the mRNA levels of collagen II, aggrecan and collagen
type X. However, TNFalpha showed less potent effects on this downreg-
ulation than Il-1. Moreover, TNFalpha did not inhibit safranin O staining
completely even at the highest concentration applied (10 ng/mL). In
contrast, safranin O staining was already fully blocked by 1.0 ng/mL Il-1,
indicating the greater potency of Il-1 in inhibiting chondrogenesis.
Addition of osteoarthritic conditioned medium, containing an unknown
mixture of anabolic and catabolic factors, strongly inhibited chondroge-
nesis of differentiating mesenchymal stem cells. Conditioned medium
of synovia of ﬁve different patients inhibited proteoglycan deposition.
In addition, chondrogenic mRNA markers were inhibited strongly in all
patients but one, in which they were slightly stimulated. These results
show that chondrogenesis of differentiating mesenchymal stem cells is
inhibited by factors produced by OA synovium.
Conclusions: Our study shows for the ﬁrst time that chondrogenesis of
human mesenchymal stem cells is blocked by single catabolic factors as
well as factors produced by osteoarthritic synovium.
Our ﬁndings have major implications for therapies that are currently being
applied or developed. Therapies such as tissue engineering or marrow
stimulation techniques depend on tissue repair and chondrogenesis by
mesenchymal stem cells. In addition, the intrinsic repair response will be
blocked by catabolic factors present in disease joints. Successful cartilage
regeneration can be expected to fail if the catabolic environment of a
damaged joint is not altered. Our study shows that transplantation of
mesenchymal stem cells is insufﬁcient and needs to be combined with
inhibition of catabolism.
485 ALTERED CHEMOTACTIC RESPONSE OF BONE MARROW
MESENCHYMAL STEM CELLS TO PDGF-BB IN PATIENTS
WITH OSTEOARTHRITIS
R. Rollı´n1, F. Marco1, J.A. Hoyas2, E. Villafuertes1, L. Lo´pez-Dura´n1,
J.A. Jover2, B. Ferna´ndez-Gutie´rrez2. 1Servicio de Cirugı´a Ortope´dica y
Traumatologı´a. Hospital Clı´nico San Carlos, Madrid, SPAIN, 2Servicio
de Reumatologı´a. Hospital Clı´nico San Carlos, Madrid, SPAIN
Purpose: Osteoarthritis (OA) is a condition that involves extensive car-
tilage and bone damage. Adult Mesenchymal Stem Cells (MSCs) are
multipotent cells whose primary reservoir is bone marrow. Following
situations of extensive tissue damage, MSC are mobilized and migrate to
the site of injury along a chemotactic gradient, contributing signiﬁcantly
to local tissue repair. Until now, various molecules that modulate chemo-
tactic migration of MSCs have been reported. Platelet-derived growth
factor (PDGF), a polypeptide formed by two amino acid chains of two
related genes, is a powerful chemotactic factor for mesenchymal cells,
including osteoblasts from human and rat tissue. The products of the
PDGF A and PDGF B genes can form homodimers or heterodimers,
so PDGF could act in three isoforms: PDGF-AA, PDGF-BB, or PDGF-
AB. PDGF-BB may be more speciﬁc for MSCs and their recruitment
from long distances, being chemoattractive for the progenitor cells even
at the lowest concentrations. The aim of this study was to assess the
chemotactic effects of PDGF-BB on primary human MSCs from patients
with OA and to compare the results with those of primary human MSCs
from healthy controls.
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Methods: Conﬂuent MSCs from 6 OA patients and 6 controls were
trypsinized, counted, and then washed once by centrifugation. Chemo-
taxis responses were measured using 24-well cell-culture chambers
(Transwell® Permeable Supports; Corning, NY), with inserts of 6.5-mm-
diameter and 8-mm pore polycarbonate membranes. Cells (2×104) in
0.1ml DMEM were seeded on the upper chambers and incubated for
2 hour at 37 ºC in 5% CO2 to allow cell attachment and spreading.
After the cells had attached to the Transwell® membranes, 0.6ml culture
medium containing 1 ng/ml rhPDGF-BB (R&D Systems Inc.) was added
to the lower compartment. Following 4 h of incubation at the same tem-
perature, the cells on the upper surface of the membrane were removed
with a cotton swab, and the remaining migrated cells on the lower side
of the ﬁlter were ﬁxed with 4% formaldehyde and stained with crystal
violet. Control wells with only DMEM in the bottom well were included in
each experiment. All measurements were from at least six independent
experiments performed in triplicate.
The number of migrated cells in the control and stimulated wells was
counted for 10 random ﬁelds per well at 100× magniﬁcation. Results
were expressed as a chemotactic index (CI). This index was determined
as the average number of migrated cells in stimulated wells divided by the
average number of migrated cells in control wells. Data were statistically
analysed with the Mann-Whitney U test for comparison of the two groups.
Results are presented as means±standard deviation. A value of P< 0.05
was considered statistically signiﬁcant.
Results: rhPDGF-BB (1 ng/ml) added to the bottom compartment of the
Transwell insert caused a signiﬁcant increase in migrating MSCs from
patients with OA compared to controls (CI: 5.13±1.19 vs. 3.35±0.42,
p = 0.043). When identical amounts of rhPDGF-BB were simultaneously
added to the both the upper and the lower compartments, the cell
migration of MSC remained unchanged.
Conclusions: These data could indicate an activation of MSCs from bone
marrow in OA in response to permanent signals sent by the bone and
cartilage damage characteristic of this disease.
486 THE PRESENCE OF A CALCIFIED INTERFACE
STRENGTHENS TISSUE ENGINEERED
CARTILAGE-SUBSTRATE INTERFACIAL SHEAR STRENGTH
J-P. St. Pierre, L. Gan, J. Wang, R.M. Pilliar, R.A. Kandel, M. Grynpas.
Mount Sinai Hospital, Toronto, ON, CANADA
Purpose: To design tissue engineered cartilage with improved attach-
ment to a porous calcium polyphosphate (CPP) bone substitute (biphasic
construct) by the formation of a zone of calciﬁed cartilage (ZCC) at the
cartilage-CPP interface zone.
Methods: Cartilage-CPP biphasic implants were formed by seeding
chondrocytes isolated from the deep-zone of bovine articular cartilage
onto the top surface of porous CPP substrates coated with a thin sol-
gel-formed hydroxyapatite ﬁlm. The cells were grown in Ham’s F12
containing 20% FBS in the absence or presence of b-glycerophosphate
supplementation to induce mineralization. After 8 weeks, tissues were
harvested and examined histologically, biochemically, by RT-PCR for gene
expression and for the shear properties of the interface between cartilage
and the substrate using a speciﬁcally designed shear test apparatus.
Results: Histological sections stained with toluidine blue and von
Kossa demonstrated cartilage tissue with a thin ZCC when cultured
in mineralization-inducing media. The ZCC was localized in the tissue
directly above the substrate, mimicking osteochondral zonal organization.
The mineral formed in cartilage in vitro under these conditions has similar
composition and crystal size to that present in the ZCC of native cartilage.
Conversely, no calciﬁcation was observed in cartilage formed in the ab-
sence of b-glycerophosphate. Collagen and glycosaminoglycan contents
were similar for tissues with and without a calciﬁed zone. Expression
levels of cartilage extracellular matrix genes including collagen type II
and type X were not affected by the generation of a ZCC. Interestingly,
the shear stiffness of the interface was increased by 2-fold in the tissue
engineered cartilage with a ZCC compared to cartilage without a ZZC.
This was associated with 240% improvement in the peak shear load
and in 340% increase in energy to failure measurements. The maximal
displacement prior to failure was similar in both tissues.
Conclusions: This study demonstrates a signiﬁcant increase in interfacial
shear properties of biphasic cartilage constructs by mimicking the zonal
organization of articular cartilage by generating a ZCC at the tissue/bone
substitute interface. Generating biphasic cartilage constructs with a cal-
ciﬁed cartilage interface will be critical for the clinical success of biphasic
constructs used to repair larger joint defects.
487 THE EFFECT OF LOW-INTENSITY PULSED ULTRASOUND
FOR FORMING OF SCAFFOLD-FREE CARTILAGE TISSUE
IN VITRO
K. Uenaka, S. Imai, K. Ando, S. Shioji, Y. Matsusue. Department of
Orthopaedic Surgery, Shiga University of Medical Science, Otsu, Shiga,
JAPAN
Purpose: The aim of this study is to evaluate the effect of low-intensity
pulsed ultrasound (LIPUS) for forming of scaffold-free cartilage in vitro
culture.
Methods: Chondrocytes were collected from articular cartilage of Wis-
tar rats. For acquirement the number of cells, the collected primary
chondrocytes (passage 0) were cultured up to subconﬂuent in 500 cm2
square dishes. The cells were then condensed to the density at 107
cells/cm2 (passage 1) on synthetic membranes. The LIPUS application
group was stimulated by LIPUS for 20min/day. The mode of the applied
ultrasound is a 200ms burst sine wave of 1.5MHz repeating at 1 kHz with
an intensity of 30mW/cm2. To investigate effect LIPUS stimulation on
the matrix-synthesis of the tissues, mRNA expression of type II collagen
(col2), aggrecan and type I collagen (col1) was studied using real-time
polymerase chain reaction. Synthesis of type II collagen and proteoglycan
was also assessed histochemically in 4weeks culture.
Results: In our previous study, we presented that high-density culture
with P1 chondrocytes more than 106 cells/cm2 could form a cell mass as
scaffold-free cartilage tissue under existing cell-cell interactions.
In this way, the chondrocytes prepared at 107 cells/cm2 automatically
detached from the membranes to form a mass of chondrocytes around
the third day of starting P1 culture. After forming the mass, they were
moved to simple 6 well dishes for oxygen and nutrition diffusion. The
expression of col2 and aggrecan mRNA was signiﬁcantly higher in the
group by stimulation of LIPUS than the group by no stimulation.
The resultant scaffold-free cartilage like tissues formed via cell conden-
sation at 107cells/cm2 grew in thickness until the 7th day of P1 culture.
They grew in size until the 14th day of P1 culture.
The tissues were stained strongly with safranin O, and there were partially
columnar pattern. Immunohistochemical analysis revealed that typeIIcol-
lagen was abundantly deposited in the tissues. Moreover with toluidine
blue staining, there was a metachromatic matrix in them. Respectively,
LIPUS stimulation group was more strongly stained than the control
group.
Conclusions: The chondrocytes of P1 cells prepared at 107 cells/cm2
developed into scaffold-free cartilage like tissue under existing cell-cell
interactions. As a result of application of LIPUS, we could form scaffold-
free cartilage like tissues which were similar to native cartilage.
488 BONE-MARROW-DERIVED CELLS (BMDCS) ONE STEP
REPAIR PROCEDURE (“ONE STEP”) VERSUS AUTOLOGOUS
CHONDROCYTE IMPLANTATION (ACI) IN SURGICAL
TREATMENT OF OSTEOCHONDRAL LESIONS OF THE
TALUS: A COMPARATIVE HISTOLOGICAL STUDY
S. Giannini, R. Buda, B. Grigolo, F. Vannini, M. Cavallo. University of
Bologna, Bologna, ITALY
Purpose: Osteochondral lesions of the talus are frequent occurrences
in young active patients. Various surgical options have been proposed
over time in order to restore a continuous and adequate cartilaginous
layer at the lesion site. Among them, only mosaicplasty and Autologous
Chondrocyte Implantation (ACI) were capable, up to now, to restore
hyaline cartilage at the lesion site, although major disadvantages of these
techniques have been widely described. These considerations leaded in
search of new methods for cartilage repair and recently the use of Bone
Marrow-Derived Cells (BMDCs) was indicated as a reliable alternative
for the treatment of articular cartilage defects. The aim of this study
was to verify the ability of an original technique based upon BMDCs
to regenerate hyaline articular cartilage, and to compare the clinical and
histological results with them obtained after ACI.
Methods: From October 2005 to April 2008, 50 patients affected by
osteochondral lesions of the talus >1.5 cm2 underwent a new arthroscopic
“One Step” procedure by using bone marrow harvested from the iliac
crest, directly concentrated in Operatory Room and seeded on a scaffold
with the addition of Platelet-Rich-Fibrin (PRF).
Patients evaluation included clinical AOFAS score, X-Rays, MRI preop-
eratively and at different established follow-up. A series of 46 patients
operated by ACI procedure and comparable for age and lesion types was
used as control group. At 12 months follow up after “One Step” procedure,
an arthroscopic second look and a biopsy of the regenerated cartilage
